The threat of the COVID-19 pandemic on reversing global life-saving gains in the survival of childhood cancer: a call for collaborative action from SIOP, IPSO, PROS, WCC, CCI, St Jude Global, UICC and WHPCA

Kathy Pritchard-Jones, Aimone de C. V. Abib, Natia Esiashvili, Gertjan J. L. Kaspers, Jon Rosser, John A. Van Doorninck, Joao M. L. Braganca, Ruth I. Hoffman, Carlos Rodriguez-Galindo, Cary Adams, Stephen R. Connor, Abdelhafeez H. Abdelhafeez, Eric Bouffet, Scott C. Howard, Julia M. Challinor, Laila Hessissen, Rashmi B. Dalvi, Pamela Kearns, Guillermo L. Chantada, Lindsay A. FrazierMichael J. Sullivan, Fiona S. M. Schulte, Lisa K. Morrissey, Olga Kozhaeva, Sandra Luna-Fineman, Muhammad S. Khan

Research output: Contribution to journalArticlepeer-review

126 Downloads (Pure)

Abstract

The COVID-19 pandemic poses an unprecedented health crisis in all socio-economic regions across the globe. While the pandemic has had a profound impact on access to and delivery of health care by all services, it has been particularly disruptive for the care of patients with life-threatening noncommunicable diseases (NCDs) such as the treatment of children and young people with cancer.

The reduction in child mortality from preventable causes over the last 50 years has seen childhood cancer emerge as a major unmet health care need. Whilst survival rates of 85% have been achieved in high income countries, this has not yet been translated into similar outcomes for children with cancer in resource-limited settings where survival averages 30%. Launched in 2018, by the World Health Organization (WHO), the Global Initiative for Childhood Cancer (GICC) is a pivotal effort by the international community to achieve at least 60% survival for children with cancer by 2030.

The WHO GICC is already making an impact in many countries but the disruption of cancer care during the COVID-19 pandemic threatens to set back this global effort to improve the outcome for children with cancer, wherever they may live.

As representatives of the global community committed to fostering the goals of the GICC, we applaud the WHO response to the COVID-19 pandemic, in particular we support the WHO’s call to ensure the needs of patients with life threatening NCDs including cancer are not compromised during the pandemic. Here, as collaborative partners in the GICC, we highlight specific areas of focus that need to be addressed to ensure the immediate care of children and adolescents with cancer is not disrupted during the pandemic; and measures to sustain the development of cancer care so the long-term goals of the GICC are not lost during this global health crisis.
Original languageEnglish
Article number1187
Number of pages10
JournalEcancermedicalscience
Volume15
DOIs
Publication statusPublished - 15 Feb 2021

Bibliographical note

Funding Information:
Publication costs for this article were supported by ecancer (UK Charity number 1176307) and the International Society of Paediatric Oncology (SIOP).

Publisher Copyright:
© the authors; licensee ecancermedicalscience. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Keywords

  • COVID-19
  • children
  • global
  • neoplasms
  • paediatric
  • policy
  • Policy
  • Paediatric
  • Children
  • Global
  • Neoplasms

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint

Dive into the research topics of 'The threat of the COVID-19 pandemic on reversing global life-saving gains in the survival of childhood cancer: a call for collaborative action from SIOP, IPSO, PROS, WCC, CCI, St Jude Global, UICC and WHPCA'. Together they form a unique fingerprint.

Cite this